References
- Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents and adults, 1999–2002. JAMA 2004; 291: 2847–50
- Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes and obesity related health risk factors, 2001. JAMA 2003; 289: 76–9
- Dupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. Br Med J 1999; 318: 1591–4
- Myles TD, Gooch J, Santolaya J. Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery. Obstet Gynecol 2002; 100: 959–64
- Baddour LM, Bisno AL. Recurrent cellulitis after coronary bypass surgery. Association with superficial fungal infection in saphenous venectomy limbs. JAMA 1984; 251: 1049–52
- Swartz MN. Cellulitis. N Engl J Med 2004; 350: 904–12
- Baddour LM. Cellulitis syndromes: an update. Int J Antimicrob Agents 2000; 14: 113–6
- Kuczmarski RJ, Flegal KM. Criteria for definition of overweight in transition: background and recommendation for the United States. Am J Clin Nutr 2000; 72: 1074–81
- Keys A, Fidanza F, Karvonen K, Chimaera N, Taylor HL. Indices of relative weight and obesity. J Chronic Dis 1972; 25: 329–43
- Falagas ME, Vergidis PI. Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med 2005; 142: 47–55
- Hook EW, 3rd, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med 1986; 146: 295–7
- Ginsberg MB. Cellulitis: analysis of 101 cases and review of the literature. South Med J 1981; 74: 530–3
- Fleisher G, Ludwig S. Cellulitis: a prospective study. Ann Emerg Med 1980; 9: 246–9
- Bearden DT, Rodwold KA. Dosage adjustments for antibacterials in obese patients. Clin Pharmacokinet 2004; 38: 415–26
- Madaras-Kelly KJ, Arbogast R, Jue S. Increased therapeutic failure for cephalexin versus comparator antibiotics in the treatment of outpatient cellulitis. Pharmacother 2000; 20: 199–205
- Baddour LM, Bisno AL. Non-group A beta-hemolytic streptococcal cellulitis. Association with venous and lymphatic compromise. Am J Med 1985; 79: 155–9
- Zackrisson G, Lind L, Roos K, Larsson P. Erythromycin-resistant beta-hemolytic streptococci group A in Goteborg, Sweden. Scand J Infect Dis 1988; 20: 419–20
- Uh Y, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea. Antimicrob Agents Chemother 2004; 48: 2716–8